← Leaderboards
Ranjan Joseph Perera
Sanford Burnham Prebys Medical Discovery Institute
$2,491,672
Attributed
$2,491,672
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $417.6K · FY2012–25$500K$375K$250K$125K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,491,672 · 4
By mechanism
R01$1,640,984 · 1
R21$466,538 · 1
R03$384,150 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularMalignant NeoplasmsDiagnosisGenesPlayNeoplasm MetastasisCell ProliferationTumorUntranslated RnaTranscriptome SequencingInsightMouse ModelPathway InteractionsRegulator GenesIn VivoInnovationAffectHuman DiseaseCellsResistanceTherapeutic TargetInduction Of ApoptosisGene Expression ProfileApoptosis
Grant awards (11)
Regulation, function, and the therapeutic potential of an oncogenic long noncoding RNA lnc-HLX-2-7 in group 3 medulloblastomas$409,375
R01 · FY2025 · NS · contact PI
Regulation, function, and the therapeutic potential of an oncogenic long noncoding RNA lnc-HLX-2-7 in group 3 medulloblastomas$396,367
R01 · FY2024 · NS · contact PI
Regulation, function, and the therapeutic potential of an oncogenic long noncoding RNA lnc-HLX-2-7 in group 3 medulloblastomas$417,621
R01 · FY2023 · NS · contact PI
Regulation, function, and the therapeutic potential of an oncogenic long noncoding RNA lnc-HLX-2-7 in group 3 medulloblastomas$417,621
R01 · FY2022 · NS · contact PI
Identification of the molecular mechanism of miR-211 and its target genes in melanocytes and pigmented melanoma senescence and apoptosis$178,078
R21 · FY2017 · CA · contact PI
Identification of the molecular mechanism of miR-211 and its target genes in melanocytes and pigmented melanoma senescence and apoptosis$33,985
R21 · FY2017 · CA · contact PI
Identification of the molecular mechanism of miR-211 and its target genes in melanocytes and pigmented melanoma senescence and apoptosis$254,475
R21 · FY2016 · CA · contact PI
The role of miR-211 and its target genes in melanoma development in humans.$97,500
R03 · FY2014 · CA · contact PI
The role of miR-211 and its target genes in melanoma development in humans.$97,500
R03 · FY2013 · CA · contact PI
Identification and characterization of long noncoding RNAs in human melanomas$91,650
R03 · FY2013 · CA · contact PI
Identification and characterization of long noncoding RNAs in human melanomas$97,500
R03 · FY2012 · CA · contact PI